PRMT5 inhibitors for lower-risk myelodysplasia: Is there anywhere to move?

Andrej Terzic; David J. Curtis

doi:10.1016/j.leukres.2023.107415

PRMT5 inhibitors for lower-risk myelodysplasia: Is there anywhere to move?

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Article number	107415
Number of pages	3
Journal	Leukemia Research
Volume	135
DOIs	https://doi.org/10.1016/j.leukres.2023.107415
Publication status	Published - Dec 2023

Keywords

Lower-risk myelodysplasia
PRMT5 inhibitors
Synthetic lethality

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.leukres.2023.107415

Cite this

@article{3d9c16a3b4e14544b8478f7b16b4062f,

title = "PRMT5 inhibitors for lower-risk myelodysplasia: Is there anywhere to move?",

keywords = "Lower-risk myelodysplasia, PRMT5 inhibitors, Synthetic lethality",

author = "Andrej Terzic and Curtis, {David J.}",

year = "2023",

month = dec,

doi = "10.1016/j.leukres.2023.107415",

language = "English",

volume = "135",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier",

}

TY - JOUR

T1 - PRMT5 inhibitors for lower-risk myelodysplasia

T2 - Is there anywhere to move?

AU - Terzic, Andrej

AU - Curtis, David J.

PY - 2023/12

Y1 - 2023/12

KW - Lower-risk myelodysplasia

KW - PRMT5 inhibitors

KW - Synthetic lethality

UR - http://www.scopus.com/inward/record.url?scp=85177977187&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2023.107415

DO - 10.1016/j.leukres.2023.107415

M3 - Comment / Debate

C2 - 37953091

AN - SCOPUS:85177977187

SN - 0145-2126

VL - 135

JO - Leukemia Research

JF - Leukemia Research

M1 - 107415

ER -

PRMT5 inhibitors for lower-risk myelodysplasia: Is there anywhere to move?

Keywords

UN SDGs

Access to Document

Other files and links

Cite this